More News

25 May 2018 Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
24 May 2018 San Diego-based Epigen Biosciences enters a collaboration to license its LPA1 Receptor small molecule program to Novo Nordisk A/S for up to USD 200 Million
23 May 2018 mAbxience and Amneal Enter Into an Agreement for Bevacizumab Biosimilar in the United States
23 May 2018 Monarch Biosciences Announces Fred Hutch Exclusive License and Presentations at BIO Regarding Cell Therapy Delivery Technology
23 May 2018 VFMCRP and Cara Therapeutics to develop and commercialise CR845 injection for chronic kidney disease-associated pruritus
23 May 2018 Evotec and Celgene enter into strategic oncology partnership
22 May 2018 Allergan Exercises Option to Acquire Compound from Aptinyx Discovery Platform Under Ongoing Research Collaboration
22 May 2018 Karo Pharma receives milestone payment for RORgamma
17 May 2018 Intellia Therapeutics Announces WT1 as Its First Cell Therapy Target, Following Presentation of Early Data at the American Society of Gene and Cell Therapy 21st Annual Meeting
16 May 2018 Fate Therapeutics and Memorial Sloan Kettering Cancer Center Expand Scope of License Agreement to include Gene-edited T-cell Immunotherapies
15 May 2018 TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform
15 May 2018 Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline
15 May 2018 Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies
14 May 2018 Lilly to Acquire AurKa Pharma
14 May 2018 Medigene significantly expands TCR alliance with bluebird bio in cancer immunotherapy
14 May 2018 Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars
10 May 2018 Lilly Announces Agreement To Acquire ARMO BioSciences
10 May 2018 FORMA Therapeutics and the University of Oxford Announce Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors for the Treatment of Neurodegenerative Diseases
10 May 2018 Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
09 May 2018 Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech
09 May 2018 Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders
08 May 2018 Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies in Oncology, Autoimmune and Other Diseases
08 May 2018 Proposed Acquisition of Shire plc by Takeda
07 May 2018 Aptose Exercises Early Option for CG-806 License From CrystalGenomics
07 May 2018 LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top